Sanford-Burnham News Archive

Burnham Institute for Medical Research Demonstrates Commitment to Translational Research with New Faculty Appointment

ORLANDO, Fla. , April 2, 2009

Burnham Institute for Medical Research at Lake Nona (Burnham) today announced that Stephen J. Gardell, Ph.D. has joined the Institute as Director of Translational Research Resources and Adjunct Associate Professor. Dr. Gardell’s appointment is an indication of Burnham’s intent to conduct basic medical research that can be quickly transferred from the laboratory to the clinic. Translational research, typically the domain of pharmaceutical laboratories, is moving downstream into not-for-profit research institutes to accelerate drug discovery and the development of diagnostic markers.

“Dr. Gardell brings a unique combination of experience to the interdisciplinary team being created at Burnham. His scientific focus aligns perfectly with our programs focused on cardiovascular and metabolic diseases. His pharmaceutical experience in drug discovery will help our mission to move discovery science to the clinic along at a faster pace,” said Dr. Daniel Kelly, Scientific Director at Burnham Lake Nona.

Dr. Gardell has extensive experience in research technology and drug development. He held senior positions at several large pharmaceutical companies, including Wyeth Laboratories where he was Assistant Vice President of Cardiovascular and Metabolic Disease. Previously, he directed obesity research at Bayer Research Center and biological chemistry at Merck Research Laboratories. Dr. Gardell received his undergraduate degree from Boston College and completed his Ph.D. studies at Cornell University in New York.

Dr. Gardell’s pharmaceutical experience, including the successful identification of several drug candidates for clinical trials, will benefit Burnham investigators, as he advises the scientists on strategies to translate laboratory discoveries into clinical applications. Dr. Gardell will also oversee development and operation of the cardiometabolic and metabolomics technology cores and conduct independent and collaborative research.

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at

Sanford-Burnham can also be found on Facebook at and on Twitter @sanfordburnham.

News & News and Press - Sanford-Burnham Boilerplate
Sign In Skip Navigation Links Skip navigation links
News Archive
Sanford-Burnham In The News
Media Contacts and Guidelines
News Search
Paper of the Week
Quarterly Science Highlights
Multimedia Resources